Holen Sie sich die Stockscreener-App
124.19
0.88%
-1.10
Handel nachbörslich:
124.19
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
The Truth About Abbott Laboratories: Is This ‘Boring’ Stock Actually a Secret Power Play? - AD HOC NEWS
Top 2 Health Care Stocks That May Crash In Q1 - Benzinga
Allspring Global Investments Holdings LLC Acquires 69,578 Shares of Abbott Laboratories $ABT - MarketBeat
Bank Pictet & Cie Europe AG Has $9.82 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature - FinancialContent
Ninety One SA PTY Ltd Takes $1.49 Million Position in Abbott Laboratories $ABT - MarketBeat
Mather Group LLC. Raises Position in Abbott Laboratories $ABT - MarketBeat
Merit Financial Group LLC Acquires 20,035 Shares of Abbott Laboratories $ABT - MarketBeat
With EPS Growth And More, Abbott Laboratories (NYSE:ABT) Makes An Interesting Case - Yahoo Finance
Abbott Laboratories (ABT): Buy, Sell, or Hold Post Q3 Earnings? - TradingView — Track All Markets
The Truth About Abbott Laboratories: Viral Hype Or Boring Boomer Stock You’re Sleeping On? - AD HOC NEWS
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance Singapore
Shum Financial Group Inc. Acquires Shares of 8,127 Abbott Laboratories $ABT - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Purchases 245,400 Shares of Abbott Laboratories $ABT - MarketBeat
Brendel Financial Advisors LLC Sells 23,978 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott stock today: ABT rises as Exact Sciences deal filing and Volt AFib device stay in focus - ts2.tech
Abbott (ABT) Wins FDA Approval for Volt PFA System in AFib Treatment - Finviz
Traders Buy Large Volume of Call Options on Abbott Laboratories (NYSE:ABT) - MarketBeat
Exact Sciences Approves Executive Bonus Acceleration Amid Abbott Merger - The Globe and Mail
Oak Harvest Investment Services Decreases Stake in Abbott Laboratories $ABT - MarketBeat
Diversified Trust Co Boosts Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock Walks a Tightrope Between Defensive Haven and Growth Re?Rating - AD HOC NEWS
U.S. Embolic Protection Devices Market and Competition - GlobeNewswire
U.S. Embolic Protection Devices Market and Competition Analysis, 2025-2033, Featuring Abbott Laboratories, Allium Medical Solutions, Boston Scientific, Cardinal Health and More - Yahoo Finance
Ethic Inc. Has $29.96 Million Position in Abbott Laboratories $ABT - MarketBeat
Tealwood Asset Management Inc. Grows Stock Position in Abbott Laboratories $ABT - MarketBeat
Rede Wealth LLC Purchases New Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Pacer Advisors Inc. - MarketBeat
Is AbbVie a Buy, Sell, or Hold in 2026? - The Motley Fool
Is Weakness In Abbott Laboratories (NYSE:ABT) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects? - Yahoo Finance
Abbott Laboratories $ABT Shares Acquired by Brookstone Capital Management - MarketBeat
What you need to know ahead of Abbott Laboratories' earnings release - MSN
V. M. Manning & CO. Inc. Makes New $2.70 Million Investment in Abbott Laboratories $ABT - MarketBeat
What You Need to Know Ahead of Abbott Laboratories' Earnings Release - Yahoo Finance
Abbott Laboratories Pakistan : Corporate Briefing Session 2025 - marketscreener.com
Abbott Laboratories $ABT Shares Sold by Covea Finance - MarketBeat
Avanza Fonder AB Purchases 10,889 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT) News and Stock Outlook on Dec. 25, 2025: FDA Clears Volt PFA, FreeStyle Libre Alert Persists, Exact Sciences Deal Looms - ts2.tech
Abbott Laboratories Stock (ABT) After Hours on Dec. 24, 2025: What to Know Before the Next Market Open on Dec. 26 - ts2.tech
Abbott Laboratories Shrugs Off Tariffs & China Headwinds With 7% Dividend Raise (NYSE:ABT) - Seeking Alpha
Swedbank AB Sells 179,009 Shares of Abbott Laboratories $ABT - MarketBeat
Vontobel Holding Ltd. Sells 1,389,990 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Purchased by IFM Investors Pty Ltd - MarketBeat
GLOBALT Investments LLC GA Boosts Stock Position in Abbott Laboratories $ABT - MarketBeat
DAVENPORT & Co LLC Has $127.05 Million Stock Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories Stock After Hours (ABT): FDA Win, Holiday Trading Dynamics, and What to Watch Before the Dec. 24 Open - ts2.tech
Abbott Laboratories (ABT) director Nita Ahuja files Form 3 with no securities owned - Stock Titan
Abbott India Limited (NSE:ABBOTINDIA) stock most popular amongst public companies who own 75%, while individual investors hold 17% - simplywall.st
Abbott Stock May Benefit Following Volt PFA's FDA Approval - Nasdaq
Is Abbott Laboratories Attractively Priced After Recent Share Price Gains And DCF Concerns? - Yahoo Finance
This Dividend Stock Just Scored an FDA Win. Should You Buy Shares Now? - Yahoo Finance
Abbott Wins FDA Clearance for Volt - Yahoo Finance
Abbott Laboratories $ABT Shares Sold by Exchange Traded Concepts LLC - MarketBeat
Abbott Laboratories: Buy Rating Backed by Volt PFA-Driven Incremental Growth and Strengthening Electrophysiology Position - TipRanks
A pleasant shock: Abbott’s Volt PFA system snags early FDA approval - BioWorld MedTech
Abbott Enters the US Pulsed Field Ablation Fray - Medical Device and Diagnostic industry
Abbott receives clearance for heart delivery device in premature babies - MedTech Dive
Abbott Claws Back More Glucose Monitoring IP On Appeal - Law360
Abbott's Volt pulsed field ablation system scores FDA approval - Fierce Biotech
Abbott's FDA OK of Volt signals big 2026 for its cardiology business - Crain's Chicago Business
Abbott receives FDA approval for Volt PFA system - MedTech Dive
Abbott PFA system gains FDA approval - Cardiovascular Business
Abbott Secures US FDA Approval for Volt Pulsed Field Ablation System for Heart Rhythm Disorder - marketscreener.com
Abbott wins FDA approval of Volt pulsed ablation device for atrial fibrillation - Seeking Alpha
Abbott Gets FDA Approval for Volt Medical Device to Treat Arrhythmia - marketscreener.com
Abbott Labs stock gains as FDA approves Volt PFA System ahead of schedule - Investing.com
Abbott earns FDA approval for Volt PFA system for AFib - MassDevice
New heart procedure uses electric pulses to treat common irregular rhythm - Stock Titan
Abbott Laboratories $ABT Shares Sold by USA Financial Formulas - MarketBeat
0.67%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):